Patents by Inventor Anny Slama Schwok

Anny Slama Schwok has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents directed against respiratory syncytial virus
    Patent number: 10213413
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: February 26, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • ANTIVIRAL COMPOSITIONS DIRECTED AGAINST THE NUCLEOPROTEIN OF INFLUENZA VIRUSES
    Publication number: 20180028478
    Abstract: Pharmaceutical compositions for the treatment of a viral infection by a type-A influenza virus are provided. The compositions include a compound having the property of acting as an inhibitor of the attachment of the viral RNA to the nucleoprotein of the type-A influenza virus, the compound having the property of binding to the binding domain of the viral RNA to the nucleoprotein. Methods of treating an infection by influenza virus by administering an effective amount of the compound to a subject are also disclosed. A process for identifying a compound having the property of binding to the binding domain of the viral RNA to the nucleoprotein of the type-A influenza viruses are further disclosed.
    Type: Application
    Filed: September 6, 2017
    Publication date: February 1, 2018
    Inventors: Anny SLAMA SCHWOK, Bernard DELMAS, Stephane QUIDEAU, Helene BERTRAND, Bogdan TARUS
  • ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS
    Publication number: 20170360752
    Abstract: The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
    Type: Application
    Filed: November 5, 2015
    Publication date: December 21, 2017
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), INSTITUT NATIONAL DE LA RECHERCHEAGRONOMIQUE, Institut Pasteur, UNIVERSITÉ PARIS-SUD
    Inventors: Christina Sizun, Stéphane Duquerroy, Jean-François Eleouet, Felix Rey, Anny Slama Schwok, Didier Desmaele, Patrick Couvreur, Bogdan Tarus
  • Antiviral compositions directed against the influenza virus nucleoprotein
    Patent number: 9783482
    Abstract: A pharmaceutical composition for treating viral infections by an influenza type A virus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein. A pharmaceutical composition for treating viral infections by an orthomyxovirus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of orthomyxoviruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein of the viruses. A compound acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and binding to the viral-RNA-binding domain on the nucleoprotein of influenza type A viruses and a method for identifying such a compound having these properties are also described.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: October 10, 2017
    Assignee: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE
    Inventors: Anny Slama Schwok, Bernard Delmas, Stephane Quideau, Helene Bertrand, Bogdan Tarus
  • Family of analogues and NADP+ or NADPH, their preparation and their application in therapeutics
    Patent number: 9409937
    Abstract: A new family of analogues of NADP+ or NADPH, their preparation and their application in therapeutics.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: August 9, 2016
    Assignee: UNIVERSITE PARIS DESCARTES
    Inventors: Anny Slama-Schwok, Jean-Luc Boucher, Yun Xu-Li, Eric Deprez, Etienne Henry, Chantal Dessy, Olivier Feron, Bogdan Tarus
  • NEW FAMILY OF ANALOGUES AND NADP+ OR NADPH, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
    Publication number: 20140193339
    Abstract: A new family of analogues of NADP+ or NADPH, their preparation and their application in therapeutics.
    Type: Application
    Filed: June 19, 2012
    Publication date: July 10, 2014
    Inventors: Anny Slama-Schwok, Jean-Luc Boucher, Yun Xu-Li, Eric Deprez, Etienne Henry, Chantal Dessy, Olivier Feron, Bogdan Tarus
  • ANTIVIRAL COMPOSITIONS DIRECTED AGAINST THE INFLUENZA VIRUS NUCLEOPROTEIN
    Publication number: 20140163107
    Abstract: A pharmaceutical composition for treating viral infections by an influenza type A virus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein. A pharmaceutical composition for treating viral infections by an orthomyxovirus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of orthomyxoviruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein of the viruses. A compound acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and binding to the viral-RNA-binding domain on the nucleoprotein of influenza type A viruses and a method for identifying such a compound having these properties are also described.
    Type: Application
    Filed: April 20, 2012
    Publication date: June 12, 2014
    Applicant: Institut National de la Recherche Agronimique
    Inventors: Anny Slama Schwok, Bernard Delmas, Stephane Quideau, Helene Bertrand, Bogdan Tarus